CRL logo

Charles River Laboratories International Inc. (CRL)

$184.79

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CRL

Market cap

$8.90B

EPS

-3.71

P/E ratio

--

Price to sales

2.05

Dividend yield

--

Beta

1.456346

Price on CRL

Previous close

$188.47

Today's open

$188.94

Day's range

$184.64 - $190

52 week range

$143.06 - $228.88

Profile about CRL

CEO

James C. Foster

Employees

19700

Headquarters

Wilmington, MA

Exchange

New York Stock Exchange

Shares outstanding

48167730

Issue type

Common Stock

CRL industries and sectors

Healthcare

Biotechnology & Life Sciences

News on CRL

LH vs. CRL: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck right now?

news source

Zacks Investment Research • Jun 15, 2026

news preview

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Jun 3, 2026

news preview

Charles River Associates (CRA) to Present at the Sidoti Small-Cap Virtual Conference

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the Company will participate in the Sidoti Small-Cap Virtual Conference on June 17 and 18, 2026. CRA Chairman and Chief Executive Officer Paul Maleh is scheduled to present at 10:00 a.m. EDT on Wednesday, June 17. A live webcast will be available on the Company's investor relations website. An archived replay will be avai.

news source

Business Wire • Jun 3, 2026

news preview

Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript

news source

Seeking Alpha • Jun 2, 2026

news preview

Charles River Laboratories to Present at William Blair and Jefferies Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at William Blair and Jefferies Conferences.

news source

Business Wire • Jun 1, 2026

news preview

Charles River Associates (CRA) to Present at Noble Capital Markets Virtual Conference

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the Company will participate in the Noble Capital Markets Virtual Equity Conference on June 3 and 4, 2026. CRA Chairman and Chief Executive Officer Paul Maleh is scheduled to present at 11:00 a.m. EDT on Wednesday, June 3. A live webcast will be available on the Company's investor relations website. An archived replay wil.

news source

Business Wire • May 26, 2026

news preview

Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • May 20, 2026

news preview

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization. The partnership will leverage Charles River's expertise in biologics and cell therapy GMP testing to support MEDIPOST's global cell therapy pipeline, starting i.

news source

Business Wire • May 13, 2026

news preview

Charles River (CRL) Reliance on International Sales: What Investors Need to Know

Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

news source

Zacks Investment Research • May 11, 2026

news preview

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study timelines, and enhances pathologist efficiency, and supports the reduction of animal use in nonclinical research where scientifically appropriate. By fully integrating digital pathology across the histology and pathology workflow, Charles River is com.

news source

Business Wire • May 11, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Charles River Laboratories International Inc.

Open an M1 investment account to buy and sell Charles River Laboratories International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CRL on M1